Jeffrey Thomas Perez - 05 Apr 2024 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Apr 2024, 21:02:46 UTC
Prior SEC filing
25 Aug 2023
Next SEC filing
03 May 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jeffrey T. Perez, by Donald P. Lehr, as attorney-in-fact

Key filing fact

Jeffrey Thomas Perez filed Form 4 for PRECIGEN, INC. (PGEN) on 09 Apr 2024.

Key facts

  • This page summarizes Jeffrey Thomas Perez's Form 4 filing for PRECIGEN, INC. (PGEN).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 09 Apr 2024, 21:02.

Change

  • Previous filing in this sequence was filed on 25 Aug 2023.
  • Current net transaction value: -$61,879.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGEN transaction

Common Stock

Options Exercise

Transaction value
Shares
+142,857
Change %
+31%
Price
Shares after
601,760
Date
05 Apr 2024
Ownership
Direct
Footnotes
F1
PGEN transaction

Common Stock

Tax liability

Transaction value
$61,879
Shares
-44,199
Change %
-7.3%
Price
$1.40
Shares after
557,561
Date
05 Apr 2024
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGEN transaction Derivative

Restricted Stock Units

Award

Transaction value
$0
Shares
+142,857
Change %
Price
$0.000000
Shares after
142,857
Date
05 Apr 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
142,857
Exercise price
Footnotes
F1, F3
PGEN transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
$0
Shares
-142,857
Change %
-100%
Price
$0.000000*
Shares after
0
Date
05 Apr 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
142,857
Exercise price
Footnotes
F1, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.

Footnote F2

Represents the number of shares of common stock withheld by the Issuer to satisfy income tax withholding obligations in connection with the settlement of the RSUs.

Footnote F3

The RSUs vested immediately upon the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .